Rogowski MA (2013) AMPA Receptors as a Molecular Target in Epilepsy Therapy; Acta Neurol Scand Suppl. 2013; (197): 9-18.
Gardiner K, et al. (2016) Discovery of the First α‑Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ‑8; Med. Chem. 2016, 59, 4753-4768
Witkin JM, Kato A, Gleason SD, Gernert D, Ornstein P, Porter W, Reel J, and Gardinier KM (2015a) Anticonvulsant and improved side-effect potential of LY3130481: the first g8-selective transmembrane AMPA receptor regulatory protein (TARP) antagonist, in Proceedings of Neuroscience 2015; 2015 Oct 17-21; Chicago. Society for Neuroscience, Washington, DC.
Akihiko S Kato, Kevin D Burris, Kevin M Gardinier, Douglas L Gernert, Warren J Porter, Jon Reel, Chunjin Ding, Yuan Tu, Douglas A Schober, Matthew R Lee, Beverly A Heinz, Thomas E Fitch, Scott D Gleason, John T Catlow, Hong Yu, Stephen M Fitzjohn, Francesca Pasqui, He Wang, Yuewei Qian, Emanuele Sher, Ruud Zwart, Keith A Wafford, Kurt Rasmussen, Paul L Ornstein, John T R Isaac, Eric S Nisenbaum, David S Bredt, & Jeffrey M Witkin (2016) Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism, in Nature Medicine published online 7 November 2016; doi:10.1038/nm.4221